C. R. Bard, Inc. (BARD, NYSE: BCR) is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of urology, oncology, vascular and surgical specialty. BARD markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities and alternate site facilities.
BARD management identified a number of challenges within their Capital Expenditure Approval process. Their paper-based processes caused a major bottleneck in gathering approvals. Documents needed to be shipped from site to site, requiring days or weeks to be approved. The inefficient workflow lacked visibility and accountability, leading to wasted time and resources. BARD leaders wished to automate and streamline the process in order to reduce cycle time of capital expense approvals.
Appian BPM Solution
Appian delivered a cloud BPM solution offering real-time visibility and accountability, with automated approval tasks and alerts. The deployment was complete in four weeks, and BARD has since experienced a dramatic reduction in cycle time for expenditure requests. BARD expects to use Appian’s platform to tackle a number of other processes in the near future, including New Product Development.